Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ipsen to buy rare disease firm Clementia for up to $1.31bn

pharmaphorumFebruary 26, 2019

Tag: Ipsen , Clementia , rare disease , acquisition

PharmaSources Customer Service